(Q37155202)
Statements
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (English)
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
C Comella
D M Simpson
A Blitzer
A Brashear
M Hallett
J Jankovic
B Karp
M Naumann
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference